Rare Disease Patient Surveys: What to Know Before Sharing Your Data

As a patient with Glanzmann thrombasthenia, your experience has value. Rare disease patient surveys can help researchers understand daily challenges, treatment burdens, and patient priorities. Before participating, it is important to understand how your information will be used, who can access it, and what privacy protections apply.

How Will Your Patient Data Be Used and Shared?

A survey may take only a few minutes, but you could provide information that is retained and used long after you complete it.

Before submitting answers, look for clear explanations of:

• Who collects your responses and who can access them.
• Whether partners receive individual responses or only combined findings.
• Whether information may be reused for future research or commercial purposes.
• How long the data will be retained.
• Whether written responses may be quoted in reports or public materials.

A familiar organization sharing the survey does not necessarily tell you who manages the data. Check the named research partners and the privacy information associated with the survey itself.

Are Anonymous Patient Surveys Truly Anonymous?

Removing names does not necessarily make information impossible to connect to a person. HHS explains that combinations of details, unusual events, and written narratives can allow identification. Even properly de-identified data can retain a small, nonzero risk of identification. HHS de-identification guidance

For a small rare disease community, this raises a practical question: could someone recognize a participant through their diagnosis, age, location, and a distinctive medical experience?

This possibility does not make every survey unsafe. It does make privacy practices worth examining. Ask what organizers mean by “anonymous,” how they reduce identification risks, and whether contact details collected for payment or follow-up are stored separately from answers.

Understanding Consent Before Taking a Survey

A short survey may come with a detailed consent form. Formal language or lengthy disclaimers alone do not establish that a project carries greater risk. Some detail may be necessary to explain the research and its protections.

Focus on what the terms allow. Are the intended uses understandable? Are privacy limitations explained? Does the consent form describe activities beyond those mentioned in the invitation?

For research covered by HHS informed-consent requirements, information must be understandable. Consent also cannot include language that makes participants waive or appear to waive legal rights or release specified parties from liability for negligence. These requirements should not be assumed to apply the same way to every online survey. HHS informed consent FAQs

If wording seems broader than the survey’s stated purpose, request a plain-language explanation before deciding whether to participate.

Who Is Funding the Rare Disease Research?

Look for the organizations commissioning, funding, and conducting the survey, as well as those receiving the results.

Academic institutions, nonprofits, pharmaceutical companies, and market research firms may play different roles within the same project. An organization’s category alone does not establish its motives, trustworthiness, or the value of its work to patients.

More useful questions include:

• What is the survey trying to learn?
• How will the findings be used?
• Is there a commercial purpose?
• Have patients helped shape the questions?
• Will participants or the community receive an accessible summary?

Commercial objectives and patient benefit can coexist. Transparency helps you decide whether the project’s purpose aligns with your expectations.

Can You Withdraw Your Survey Responses?

Withdrawing from a study does not necessarily mean that previously submitted information will be deleted. HHS guidance allows researchers within its scope to retain and analyze data collected before a participant withdraws. HHS guidance on withdrawal from research

Ask whether you can request removal of your responses, whether a deadline applies, and what limitations exist once information has been combined, shared, or stripped of identifying links.

It is also important to understand which privacy protections apply. In the United States, HIPAA covers specified entities and their business associates; an organization does not automatically fall under HIPAA simply because it collects health information. Other protections may apply depending on the circumstances and jurisdiction. HHS explanation of HIPAA coverage

Making an Informed Decision About Participation

Patient surveys can help bring overlooked experiences into research. Asking questions supports informed participation and gives organizers a chance to demonstrate transparency.

Before clicking “submit,” you should be able to understand the project’s purpose, the intended uses of your information, and the limits of the protections offered.

Your experience has value. Sharing it should be a decision you can make clearly and confidently.